Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2007 Aug;99(8):948–950.

Diffuse large B-cell lymphoma mimicking advanced basal cell carcinoma.

Emmanuel Akinyemi 1, Le Mai 1, Abu Matin 1, Archana Maini 1
PMCID: PMC2574298  PMID: 17722675

Abstract

Primary cutaneous B-cell lymphomas (PCBCLs) are made up of a heterogenous group of B-cell lymphoproliferative diseases confined to the skin at the time of diagnosis with no evidence of extracutaneous involvement. With early diagnosis and adequate treatment, PCBCLs as a group has excellent prognosis, with about a 95% survival rate at five years. We report a case of diffuse large B-cell lymphoma (DLBCL) in a 52-year-old woman presenting as a fungating skin ulcer mimicking advanced basal cell carcinoma. Review of available literature showed most studies of PCBCLs being done on Europeans with no universally acceptable system of classification. Clinical findings, diagnostic evaluations and treatment outcomes of PCBCLs are discussed with emphasis on comparison of European Organization for Research and Treatment of Cancer (EORTC) and the World Health Organization (WHO) Classification of Neoplasms of the Hematopoietic and Lymphoid Tissue classification systems.

Full text

PDF
948

Images in this article

949Figure 1
on p.949
949Figure 2
on p.949

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Garbea A., Dippel E., Hildenbrand R., Bleyl U., Schadendorf D., Goerdt S. Cutaneous large B-cell lymphoma of the leg masquerading as a chronic venous ulcer. Br J Dermatol. 2002 Jan;146(1):144–147. doi: 10.1046/j.0007-0963.2001.04520.x. [DOI] [PubMed] [Google Scholar]
  2. Geelen F. A., Vermeer M. H., Meijer C. J., Van der Putte S. C., Kerkhof E., Kluin P. M., Willemze R. bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related. J Clin Oncol. 1998 Jun;16(6):2080–2085. doi: 10.1200/JCO.1998.16.6.2080. [DOI] [PubMed] [Google Scholar]
  3. Grønbaek K., Møller P. H., Nedergaard T., Thomsen K., Baadsgaard O., Hou-Jensen K., Zeuthen J., Guldberg P., Ralfkiaer E. Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases. Br J Dermatol. 2000 May;142(5):913–923. doi: 10.1046/j.1365-2133.2000.03471.x. [DOI] [PubMed] [Google Scholar]
  4. Hainsworth J. D., Burris H. A., 3rd, Morrissey L. H., Litchy S., Scullin D. C., Jr, Bearden J. D., 3rd, Richards P., Greco F. A. Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma. Blood. 2000 May 15;95(10):3052–3056. [PubMed] [Google Scholar]
  5. Heinzerling L. M., Urbanek M., Funk J. O., Peker S., Bleck O., Neuber K., Burg G., von Den Driesch P., Dummer R. Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma. Cancer. 2000 Oct 15;89(8):1835–1844. [PubMed] [Google Scholar]
  6. Hembury Thomas A., Lee Benita, Gascoyne Randy D., Macpherson Nicol, Yang Bin, House Nancy, Medeiros L. Jeffrey, Hsi Eric D. Primary cutaneous diffuse large B-cell lymphoma: a clinicopathologic study of 15 cases. Am J Clin Pathol. 2002 Apr;117(4):574–580. doi: 10.1309/edal-r8ha-u3el-t37d. [DOI] [PubMed] [Google Scholar]
  7. Hoefnagel J. J., Vermeer M. H., Jansen P. M., Fleuren G. J., Meijer C. J. L. M., Willemze R. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance. Br J Dermatol. 2003 Dec;149(6):1183–1191. doi: 10.1111/j.1365-2133.2003.05649.x. [DOI] [PubMed] [Google Scholar]
  8. Kirova Y. M., Piedbois Y., Le Bourgeois J. P. Radiotherapy in the management of cutaneous B-cell lymphoma. Our experience in 25 cases. Radiother Oncol. 1999 Jul;52(1):15–18. doi: 10.1016/s0167-8140(99)00089-4. [DOI] [PubMed] [Google Scholar]
  9. Liu Q., Ohshima K., Kikuchi M. Primary cutaneous B-cell lymphoma in Japanese patients. Pathol Int. 2000 Dec;50(12):960–966. doi: 10.1046/j.1440-1827.2000.01151.x. [DOI] [PubMed] [Google Scholar]
  10. Mirza I., Macpherson N., Paproski S., Gascoyne R. D., Yang B., Finn W. G., Hsi E. D. Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features. J Clin Oncol. 2002 Feb 1;20(3):647–655. doi: 10.1200/JCO.2002.20.3.647. [DOI] [PubMed] [Google Scholar]
  11. Paul T., Radny P., Kröber S. M., Paul A., Blaheta H. J., Garbe C. Intralesional rituximab for cutaneous B-cell lymphoma. Br J Dermatol. 2001 Jun;144(6):1239–1243. doi: 10.1046/j.1365-2133.2001.04241.x. [DOI] [PubMed] [Google Scholar]
  12. Piccinno R., Caccialanza M., Berti E., Baldini L. Radiotherapy of cutaneous B cell lymphomas: our experience in 31 cases. Int J Radiat Oncol Biol Phys. 1993 Sep 30;27(2):385–389. doi: 10.1016/0360-3016(93)90251-p. [DOI] [PubMed] [Google Scholar]
  13. Prince H. Miles, O'Keefe Rod, McCormack Christopher, Ryan Gail, Turner Hugh, Waring Paul, Baker Chris. Cutaneous lymphomas: which pathological classification? Pathology. 2002 Feb;34(1):36–45. doi: 10.1080/00313020120105615. [DOI] [PubMed] [Google Scholar]
  14. Roguedas A. M., Watier H., Paintaud G., de Muret A., Vaillant L., Machet L. Intralesional therapy with anti-CD20 monoclonal antibody rituximab: local and systemic efficacy in primary cutaneous B-cell lymphoma. Br J Dermatol. 2005 Mar;152(3):541–544. doi: 10.1111/j.1365-2133.2005.06433.x. [DOI] [PubMed] [Google Scholar]
  15. Tanaka M., Ichinohasama R., Iwasaki M., Sato M., Tagami H. Primary cutaneous B-cell lymphomas in Japan. A report of three cases and a comparison of Japanese and white patients. J Am Acad Dermatol. 1994 Jul;31(1):54–60. doi: 10.1016/s0190-9622(94)70135-0. [DOI] [PubMed] [Google Scholar]
  16. Willemze R., Kerl H., Sterry W., Berti E., Cerroni L., Chimenti S., Diaz-Peréz J. L., Geerts M. L., Goos M., Knobler R. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood. 1997 Jul 1;90(1):354–371. [PubMed] [Google Scholar]
  17. Willemze R., Meijer C. J. EORTC classification for primary cutaneous lymphomas: the best guide to good clinical management. European Organization for Research and Treatment of Cancer. Am J Dermatopathol. 1999 Jun;21(3):265–273. doi: 10.1097/00000372-199906000-00011. [DOI] [PubMed] [Google Scholar]
  18. Yap Lee Mei, Blum Robert, Foley Peter, McCormack Christopher, Turner Hugh, Seymour John F., Prince H. Miles. Clinical study of primary cutaneous B-cell lymphoma using both the European Organization for Research and Treatment of Cancer and World Health Organization classifications. Australas J Dermatol. 2003 May;44(2):110–115. doi: 10.1046/j.1440-0960.2003.00655.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES